These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33575424)

  • 1. Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents.
    Miller MA; Molina KC; Gutman JA; Scherger S; Lum JM; Mossad SB; Burgess M; Cheng MP; Chuang ST; Jacobs SE; Melendez DP; Shah DP; Zimmer A; Sohail MR; Syed S; Walker RC; Poeschla EM; Abidi MZ
    Open Forum Infect Dis; 2021 Feb; 8(2):ofaa646. PubMed ID: 33575424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).
    Salmanton-García J; Seidel D; Koehler P; Mellinghoff SC; Herbrecht R; Klimko N; Ráčil Z; Falces-Romero I; Ingram P; Benítez-Peñuela MÁ; Rodríguez JY; Desoubeaux G; Barać A; García-Vidal C; Hoenigl M; Mehta SR; Cheng MP; Klyasova G; Heinz WJ; Iqbal N; Krause R; Ostermann H; Penack O; Schalk E; Sheppard DC; Willinger B; Wisplinghoff H; Vehreschild JJ; Cornely OA; Vehreschild MJGT;
    J Antimicrob Chemother; 2019 Nov; 74(11):3315-3327. PubMed ID: 31393591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor outcome associated with mucormycosis in critically ill hematological patients: results of a multicenter study.
    Jestin M; Azoulay E; Pène F; Bruneel F; Mayaux J; Murgier M; Darmon M; Valade S
    Ann Intensive Care; 2021 Feb; 11(1):31. PubMed ID: 33569700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.
    Pana ZD; Seidel D; Skiada A; Groll AH; Petrikkos G; Cornely OA; Roilides E;
    BMC Infect Dis; 2016 Nov; 16(1):667. PubMed ID: 27832748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhino-Orbital-Cerebral Mucormycosis after Allogeneic Hematopoietic Stem Cell Transplantation and Isavuconazole Therapeutic Drug Monitoring during Intestinal Graft versus Host Disease.
    Andreani G; Fadda G; Gned D; Dragani M; Cavallo G; Monticone V; Morotti A; De Gobbi M; Guerrasio A; Barbui AM; D'Avolio A; Cilloni D
    Mediterr J Hematol Infect Dis; 2019; 11(1):e2019061. PubMed ID: 31700586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucormycosis.
    Reid G; Lynch JP; Fishbein MC; Clark NM
    Semin Respir Crit Care Med; 2020 Feb; 41(1):99-114. PubMed ID: 32000287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucormycosis in Mainland China: A Systematic Review of Case Reports.
    Wei LW; Zhu PQ; Chen XQ; Yu J
    Mycopathologia; 2022 Feb; 187(1):1-14. PubMed ID: 34855101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
    Hachem RY; Boktour MR; Hanna HA; Husni RN; Torres HA; Afif C; Kontoyiannis DP; Raad II
    Cancer; 2008 Mar; 112(6):1282-7. PubMed ID: 18224662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
    Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
    Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
    Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucormycosis in renal transplant recipients: review of 174 reported cases.
    Song Y; Qiao J; Giovanni G; Liu G; Yang H; Wu J; Chen J
    BMC Infect Dis; 2017 Apr; 17(1):283. PubMed ID: 28420334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Stern A; Su Y; Lee YJ; Seo S; Shaffer B; Tamari R; Gyurkocza B; Barker J; Bogler Y; Giralt S; Perales MA; Papanicolaou GA
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1195-1202. PubMed ID: 32088367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group.
    Herbrecht R; Patterson TF; Slavin MA; Marchetti O; Maertens J; Johnson EM; Schlamm HT; Donnelly JP; Pappas PG
    Clin Infect Dis; 2015 Mar; 60(5):713-20. PubMed ID: 25414266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant.
    Dagher H; Hachem R; Chaftari AM; Jiang Y; Ali S; Deeba R; Shah S; Raad I
    J Fungi (Basel); 2022 Jan; 8(1):. PubMed ID: 35050014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.
    Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G
    Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive mucormycosis in children with cancer: A retrospective study from the Infection Working Group of Italian Pediatric Hematology Oncology Association.
    Muggeo P; Calore E; Decembrino N; Frenos S; De Leonardis F; Colombini A; Petruzziello F; Perruccio K; Berger M; Burnelli R; Zanazzo GA; Santoro N; Cesaro S
    Mycoses; 2019 Feb; 62(2):165-170. PubMed ID: 30338581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isavuconazole Prophylaxis in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.
    Fontana L; Perlin DS; Zhao Y; Noble BN; Lewis JS; Strasfeld L; Hakki M
    Clin Infect Dis; 2020 Feb; 70(5):723-730. PubMed ID: 30958538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and Treatment of Invasive Mold Diseases.
    Lee SO
    Infect Chemother; 2023 Mar; 55(1):10-21. PubMed ID: 36603818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.